Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-03-23
1993-09-07
Russell, Mark
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514309, 514310, 514311, 514312, 514313, 514314, 5142242, 514290, 542 51, 542 52, 546 90, 546141, 546142, 546143, 546144, 546147, 546148, 546155, 546156, 546157, 546159, 546160, 546171, 546172, 546174, 546175, 546167, 549 12, 549354, A61K 3147, C07D40112
Patent
active
052429318
ABSTRACT:
Novel Tricyclic compound represented by formula ##STR1## possess a TXA.sub.2 biosynthesis inhibiting act and/or a TXA.sub.2 receptor antagonizing activity, and are expected to have preventive and therapeutic effects on ischemic diseases, cerebro-vascular diseases, etc.
REFERENCES:
patent: 3354155 (1967-11-01), Tretler
patent: 3420851 (1969-01-01), Bloom et al.
patent: 4282365 (1981-08-01), Rokach et al.
patent: 4396550 (1983-08-01), Takizawa et al.
patent: 4465835 (1984-08-01), Takizawa et al.
patent: 4585788 (1986-04-01), Helsley et al.
patent: 4596804 (1986-06-01), Takizawa et al.
patent: 4749703 (1988-06-01), Uno et al.
patent: 4999363 (1991-03-01), Oshima et al.
patent: 5118701 (1992-06-01), Oshima et al.
Ueno et al., J. Med Chem, "6,11-Dihydroxodibenz[b,e]oxepin acetic acid with Potent Antiinflammatory Activity," 19(7), pp. 941-976 (1976).
Tsukada et al., J. Med. Chem., "Non steroidal Antiinflammatory Agents" 21(7) pp. 633-639 (1978).
Aultz et al., J. Med Chem., "Dibenz[b,e]oxepin alkanoic acids as Nonsteroidal Antiinflammatory Agents" 20(11) pp. 1499-1501 (1977).
Metusova et al., Arz. Forsch "Pharmakologische Eigenschaften der . . . " 13, pp. 1039-1045 (1963).
Ishii Akio
Karasawa Akira
Kubo Kazuhiro
Miki Ichiro
Obase Hiroyuki
Kyowa Hakko Kogyo Co. Ltd.
Russell Mark
LandOfFree
Tricyclic compounds as TXA.sub.2 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic compounds as TXA.sub.2 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic compounds as TXA.sub.2 antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-488040